In contrast, PKMYT1 displays a distinct substrate specificity towards CDK1 and is associated with enhanced metastatic potential and diminished overall survival in colorectal and breast cancers, highlighting its role as a potential prognostic biomarker [5, 39, 40]. This evidence concerns the gene CDK1 and breast carcinoma.